BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28882191)

  • 1. Effects of sustained i.c.v. infusion of lupus CSF and autoantibodies on behavioral phenotype and neuronal calcium signaling.
    Kapadia M; Bijelić D; Zhao H; Ma D; Stojanovich L; Milošević M; Andjus P; Šakić B
    Acta Neuropathol Commun; 2017 Sep; 5(1):70. PubMed ID: 28882191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.
    Levite M
    J Neural Transm (Vienna); 2014 Aug; 121(8):1029-75. PubMed ID: 25081016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies and the brain: anti-N-methyl-D-aspartate receptor antibody and the clinical effects in patients with systemic lupus erythematosus.
    Arinuma Y
    Curr Opin Neurol; 2018 Jun; 31(3):294-299. PubMed ID: 29474315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal antibodies and brain damage in autoimmune MRL mice.
    Stanojcic M; Loheswaran G; Xu L; Hoffman SA; Sakic B
    Brain Behav Immun; 2010 Feb; 24(2):289-97. PubMed ID: 19853033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropsychiatric disease in Sjögren's syndrome: anti-ribosomal P and anti-neuronal antibodies.
    Spezialetti R; Bluestein HG; Peter JB; Alexander EL
    Am J Med; 1993 Aug; 95(2):153-60. PubMed ID: 8356981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of autoimmune depression in mice by anti-ribosomal P antibodies via the limbic system.
    Katzav A; Solodeev I; Brodsky O; Chapman J; Pick CG; Blank M; Zhang W; Reichlin M; Shoenfeld Y
    Arthritis Rheum; 2007 Mar; 56(3):938-48. PubMed ID: 17328071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of psychiatric manifestations with antibodies to ribosomal P proteins in systemic lupus erythematosus.
    Schneebaum AB; Singleton JD; West SG; Blodgett JK; Allen LG; Cheronis JC; Kotzin BL
    Am J Med; 1991 Jan; 90(1):54-62. PubMed ID: 1986591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases.
    Kang EH; Shen GQ; Morris R; Metzger A; Lee EY; Lee YJ; Lee EB; Song YW
    Lupus; 2008 Jan; 17(1):21-5. PubMed ID: 18089679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-P ribosomal antibodies induce defect in smell capability in a model of CNS -SLE (depression).
    Katzav A; Ben-Ziv T; Chapman J; Blank M; Reichlin M; Shoenfeld Y
    J Autoimmun; 2008 Dec; 31(4):393-8. PubMed ID: 18947972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions.
    Kelly MC; Denburg JA
    J Rheumatol; 1987 Aug; 14(4):740-4. PubMed ID: 3668979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S; Arinuma Y; Takayama M; Yoshio T
    Arthritis Res Ther; 2007; 9(3):R44. PubMed ID: 17472755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus.
    Golombek SJ; Graus F; Elkon KB
    Arthritis Rheum; 1986 Sep; 29(9):1090-7. PubMed ID: 3753538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective Impairment of Spatial Cognition Caused by Autoantibodies to the N-Methyl-D-Aspartate Receptor.
    Chang EH; Volpe BT; Mackay M; Aranow C; Watson P; Kowal C; Storbeck J; Mattis P; Berlin R; Chen H; Mader S; Huerta TS; Huerta PT; Diamond B
    EBioMedicine; 2015 Jul; 2(7):755-64. PubMed ID: 26286205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-ELISA detection of antineuronal antibodies in central nervous system involvement in systemic lupus erythematosus.
    Zhang X; Shu H; Zhang F; Tian X; Dong Y
    Ann Rheum Dis; 2007 Apr; 66(4):530-2. PubMed ID: 16905576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for intrathecal synthesis of autoantibodies in systemic lupus erythematosus with neurological involvement.
    Mevorach D; Raz E; Steiner I
    Lupus; 1994 Apr; 3(2):117-21. PubMed ID: 7920611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal BC RNA Transport Impairments Caused by Systemic Lupus Erythematosus Autoantibodies.
    Muslimov IA; Iacoangeli A; Eom T; Ruiz A; Lee M; Stephenson S; Ginzler EM; Tiedge H
    J Neurosci; 2019 Sep; 39(39):7759-7777. PubMed ID: 31405929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered neuroendocrine status at the onset of CNS lupus-like disease.
    Loheswaran G; Kapadia M; Gladman M; Pulapaka S; Xu L; Stanojcic M; Sakic B
    Brain Behav Immun; 2013 Aug; 32():86-93. PubMed ID: 23466502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Psychiatric manifestations of lupus erythematosus systemic and Sjogren's syndrome].
    Ampélas JF; Wattiaux MJ; Van Amerongen AP
    Encephale; 2001; 27(6):588-99. PubMed ID: 11865567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus.
    Husebye ES; Sthoeger ZM; Dayan M; Zinger H; Elbirt D; Levite M; Mozes E
    Ann Rheum Dis; 2005 Aug; 64(8):1210-3. PubMed ID: 15708887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.